An employee at a large healthcare provider on the West Coast leaked information from mandatory staff training that promotes transitioning children as young as 4 years old.
The employee at Kaiser Permanente requested to remain anonymous, according to Libs of TikTok, who first reported the story.
Read More
Puberty blockers are widely touted by doctors and transgender activists as a safe and fully reversible way to pause puberty for children with gender identity issues, but a growing body of evidence is challenging those claims, according to The New York Times.
The drug prevents the surge in bone density that would normally occur during puberty, and patients can see lifelong bone issues that are never resolved, according to the Monday NYT article. Medical professionals are also challenging claims that the drug is reversible, arguing instead that blocking puberty permanently cements a child’s transgender identity and puts them on a path to lifelong biomedical intervention.
Read More
A young woman is suing Kaiser Permanente over cross-sex medical interventions allegedly she received there as a minor, including a double mastectomy and cross-sex hormones, according to her attorneys.
Chloe Cole went on puberty blockers and cross-sex hormones and received a double mastectomy to remove her breasts between ages 13 to 17 before she stopped identifying as transgender, according to her attorneys. Cole’s lawsuit alleges that Kaiser Permanente falsely told her and her parents she was at high risk for suicide if she didn’t socially and medically transition to the opposite sex; she is seeking damages for oppression, malice and fraud.
Read More